HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Continuing FDA Regulation Doesn't Dampen Cannabis Investment Enthusiasm

Executive Summary

Anheuser-Busch's parent firm partners with Canadian firm Tilray, which makes and distributes cannabis supplements as well as dried cannabis, to research non-alcohol beverages containing tetrahydrocannabinol and cannabidiol.Similar moves by other firms entering the cannabis product market and mounting investments by US firms already in the space follow Congress' passage of the latest farm bill with a provision that substantially changes federal regulations for production and marketing of hemp.

Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

RS148401

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel